Connection

WILLIAM PEACOCK to Hemorrhage

This is a "connection" page, showing publications WILLIAM PEACOCK has written about Hemorrhage.
Connection Strength

3.413
  1. CHA2DS2-VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban. Ann Emerg Med. 2017 May; 69(5):541-550.e1.
    View in: PubMed
    Score: 0.418
  2. Safety of direct oral anticoagulants: insights from postmarketing studies. Am J Emerg Med. 2016 Nov; 34(11S):9-13.
    View in: PubMed
    Score: 0.413
  3. Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation. J Am Coll Cardiol. 2016 09 06; 68(10):1144-6.
    View in: PubMed
    Score: 0.412
  4. Safety of Direct Oral Anticoagulants: Insights from Postmarketing Studies. Am J Med. 2016 Nov; 129(11S):S41-S46.
    View in: PubMed
    Score: 0.411
  5. Managing bleeding and emergency reversal of newer oral anticoagulants: a review for primary care providers. Hosp Pract (1995). 2014 Oct; 42(4):75-82.
    View in: PubMed
    Score: 0.360
  6. Emergency management of bleeding associated with old and new oral anticoagulants. Clin Cardiol. 2012 Dec; 35(12):730-7.
    View in: PubMed
    Score: 0.309
  7. The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants. Am J Emerg Med. 2020 06; 38(6):1163-1170.
    View in: PubMed
    Score: 0.129
  8. A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban. Curr Med Res Opin. 2017 09; 33(9):1717-1723.
    View in: PubMed
    Score: 0.109
  9. Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus. Am J Cardiol. 2017 Mar 01; 119(5):753-759.
    View in: PubMed
    Score: 0.105
  10. Multicenter Trial of Rivaroxaban for Early Discharge of Pulmonary Embolism From the Emergency Department (MERCURY PE): Rationale and Design. Acad Emerg Med. 2016 11; 23(11):1280-1286.
    View in: PubMed
    Score: 0.104
  11. Is Rivaroxaban Associated With Shorter Hospital Stays and Reduced Costs Versus Parenteral Bridging to Warfarin Among Patients With Pulmonary Embolism? Clin Appl Thromb Hemost. 2017 Oct; 23(7):830-837.
    View in: PubMed
    Score: 0.102
  12. Rates of major bleeding with rivaroxaban in real-world studies of nonvalvular atrial fibrillation patients: a meta-analysis. Curr Med Res Opin. 2016 06; 32(6):1117-20.
    View in: PubMed
    Score: 0.100
  13. Target-specific Oral Anticoagulants in the Emergency Department. J Emerg Med. 2016 Feb; 50(2):246-57.
    View in: PubMed
    Score: 0.097
  14. Elevated international normalized ratio in the ED: clinical course and physician adherence to the published recommendations. Am J Emerg Med. 2005 Jan; 23(1):40-4.
    View in: PubMed
    Score: 0.046
  15. Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysis. Eur Heart J. 2024 Aug 21; 45(32):2933-2950.
    View in: PubMed
    Score: 0.045
  16. Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source: NAVIGATE-ESUS Trial. Stroke. 2020 07; 51(7):2139-2147.
    View in: PubMed
    Score: 0.033
  17. Anticoagulant Reversal Strategies in the Emergency Department Setting: Recommendations of a Multidisciplinary Expert Panel. Ann Emerg Med. 2020 10; 76(4):470-485.
    View in: PubMed
    Score: 0.032
  18. The value of sPESI for risk stratification in patients with pulmonary embolism. J Thromb Thrombolysis. 2019 Jul; 48(1):149-157.
    View in: PubMed
    Score: 0.031
  19. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. N Engl J Med. 2018 Jun 07; 378(23):2191-2201.
    View in: PubMed
    Score: 0.029
  20. Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies. Curr Med Res Opin. 2017 09; 33(9):1697-1703.
    View in: PubMed
    Score: 0.027
  21. Overall Effectiveness of Rivaroxaban in Patients with Pulmonary Embolism. Clin Ther. 2017 Jul; 39(7):1426-1436.e2.
    View in: PubMed
    Score: 0.027
  22. Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status. Int J Clin Pract. 2017 Jan; 71(1).
    View in: PubMed
    Score: 0.026
  23. Outcomes related to variation in hospital pulmonary embolus observation stay utilization. Hosp Pract (1995). 2016 Aug; 44(3):133-7.
    View in: PubMed
    Score: 0.025
  24. Evaluation and management of the atrial fibrillation patient: a report from the Society of Cardiovascular Patient Care. Crit Pathw Cardiol. 2013 Sep; 12(3):107-15.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.